Effectiveness and security of use of Sitagliptin in addition to an ongoing treatment by metformin in patients with non-controlled type 2 diabetes by metformin in monotherapy

被引：0
|
作者：
Charbonnel, B.
Valensi, P.
Giral, P.
机构：
[1] Serv Diabet, Nantes, France
[2] Univ Paris 13, Hop Jean Verdier, Serv Endocrinol Diabet Nutr, F-93430 Villetaneuse, France
[3] Hop La Pitie Salpetriere, Serv Endocrinol, Paris, France
来源：
DIABETES & METABOLISM | 2007年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 174 - 181
  • [2] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
    Afshin Salsali
    Richard E Pratley
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 450 - 451
  • [3] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [4] Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin
    Derosa, Giuseppe
    Carbone, Anna
    D'Angelo, Angela
    Querci, Fabrizio
    Fogari, Elena
    Cicero, Arrigo F. G.
    Maffioli, Pamela
    [J]. INTERNAL MEDICINE, 2013, 52 (19) : 2179 - 2187
  • [5] Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
    Derosa, Giuseppe
    Maffioli, Pamela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Ragonesi, Pietro D.
    Querci, Fabrizio
    Franzetti, Ivano G.
    Gadaleta, Gennaro
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    D'Angelo, Angela
    Cicero, Arrigo F. G.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (06): : 887 - 895
  • [6] Efficacy and safety of sitagliptin added to ongoing metformin therapy in type 2 diabetes patients who were inadequately controlled on metformin alone
    Meininger, G.
    Charbonnel, B.
    Karasik, A.
    Liu, J.
    Wu, M.
    Meehan, A.
    [J]. DIABETOLOGIA, 2006, 49 : 5 - 6
  • [7] Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
    Rhee, Eun Jung
    Min, Kyung Wan
    Jang, Hak Chul
    Nam-Goong, Il Seong
    Chung, Choon Hee
    Park, Joong Yeol
    Bae, Hak Yeon
    Kim, Doo-Man
    Baik, Sei Hyun
    Lee, Moon-Kyu
    Kim, Byung-Joon
    Chang, Sang Ah
    Ahn, Chul Woo
    Kim, Yong Seong
    Yoon, Kun Ho
    Park, Kyong Soo
    Kim, Hae Jin
    Shivane, Vyankatesh K.
    Sosale, Aravind R.
    Dharmalingam, Mala
    Gandhi, Pramod
    Gupta, Sandeep Kumar
    Pitale, Shailesh
    Agarwal, Pankaj Kumar
    Rais, Nadeem
    Mohan, V.
    Mahesh, Uma
    Kim, Jeong Ae
    Kim, Pan Kyung
    Kim, Sun Woo
    [J]. DIABETES, 2012, 61 : A291 - A291
  • [8] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    [J]. DIABETOLOGIA, 2012, 55 : S352 - S352
  • [9] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Commentary
    Salsali, Afshin
    Pratley, Richard E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 450 - 451
  • [10] The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes*
    Yang, Wenying
    Guan, Yanfen
    Shentu, Yue
    Li, Zhi
    Johnson-Levonas, Amy O.
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Alba, Maria
    [J]. JOURNAL OF DIABETES, 2012, 4 (03) : 227 - 237
12345